RxDC Resources at Amwins Connect
As we get closer to the deadline, you are probably receiving questions from your clients asking you what the carriers are doing or what are they not doing in order to report the required RxDC information. The upcoming deadline is the third round of reporting and all group health plans must submit the required employer sponsored plan and prescription drug information for calendar year 2023 to CMS by June 1, 2024.
All employer-sponsored medical plans, whether fully insured or self-insured (and regardless of size or grandfathered status), are subject to the annual prescription drug and health care spending data submission requirements under Section 204 of the Consolidated Appropriations Act, 2021 (“CAA”). This requirement is commonly referred to as the Prescription Drug Data Collection (RxDC).
Amwins Connect has been receiving information from the carriers for the past few months. Amwins Connect resources page is updated as fast as the information is coming in.
Amwins Connect RxDC Resources
The chart on our Amwins Connect RxDC Resouces' page lists the carriers’ responses. If you scroll to the bottom of the website page, there are articles specific to the different carrier updates. Also, at the bottom of the page, there is a link to the webinar by Benefit Comply providing a ‘refresher’ on the requirements and how employers may need to participate in this third round of reporting.
While every effort has been taken in compiling this information to ensure that its contents are totally accurate, neither the publisher nor the author can accept liability for any inaccuracies or changed circumstances of any information herein or for the consequences of any reliance placed upon it. This publication is distributed on the understanding that the publisher is not engaged in rendering legal, accounting, or other professional advice or services. Readers should always seek professional advice before entering into any commitments.